143 related articles for article (PubMed ID: 11983016)
1. Production and characterization of a pig line transgenic for human membrane cofactor protein.
Zhou CY; McInnes E; Parsons N; Langford G; Lancaster R; Richards A; Pino-Chavez G; Dos Santos Cruz G; Copeman L; Carrington C; Thompson S
Xenotransplantation; 2002 May; 9(3):183-90. PubMed ID: 11983016
[TBL] [Abstract][Full Text] [Related]
2. Expression of complement regulatory proteins on islets of Langerhans: a comparison between human islets and islets isolated from normal and hDAF transgenic pigs.
Bennet W; Björkland A; Sundberg B; Brandhorst D; Brendel MD; Richards A; White DJ; Nilsson B; Groth CG; Korsgren O
Transplantation; 2001 Jul; 72(2):312-9. PubMed ID: 11477359
[TBL] [Abstract][Full Text] [Related]
3. Transgenic expression in pig hearts of both human decay-accelerating factor and human membrane cofactor protein does not provide an additional benefit to that of human decay-accelerating factor alone in pig-to-baboon xenotransplantation.
Mañez R; Lopez-Pelaez E; Centeno A; Herrera JM; Juffe A; Domenech N; Harrison R; Schuurman HJ
Transplantation; 2004 Sep; 78(6):930-3. PubMed ID: 15385816
[TBL] [Abstract][Full Text] [Related]
4. Transgenic pigs expressing human CD59, in combination with human membrane cofactor protein and human decay-accelerating factor.
Zhou CY; McInnes E; Copeman L; Langford G; Parsons N; Lancaster R; Richards A; Carrington C; Thompson S
Xenotransplantation; 2005 Mar; 12(2):142-8. PubMed ID: 15693845
[TBL] [Abstract][Full Text] [Related]
5. Transgenic pigs expressing human decay-accelerating factor regulated by porcine MCP gene promoter.
Murakami H; Nagashima H; Takahagi Y; Miyagawa S; Fujimura T; Toyomura K; Nakai R; Yamada M; Kurihara T; Shigehisa T; Okabe M; Seya T; Shirakura R; Kinoshita T
Mol Reprod Dev; 2002 Mar; 61(3):302-11. PubMed ID: 11835575
[TBL] [Abstract][Full Text] [Related]
6. Characterization of pigs transgenic for human decay-accelerating factor.
Cozzi E; Tucker AW; Langford GA; Pino-Chavez G; Wright L; O'Connell MJ; Young VJ; Lancaster R; McLaughlin M; Hunt K; Bordin MC; White DJ
Transplantation; 1997 Nov; 64(10):1383-92. PubMed ID: 9392299
[TBL] [Abstract][Full Text] [Related]
7. Human DAF on pig cells protects against human and non-human primate sera cytotoxicity mediated by exogenous or endogenous complement, as determined by flow cytometry.
Díaz-Román TM; Mañez R; López-Pelaez E; Centeno A; Moscoso I; Pértegaz S; Doménech N
Transpl Immunol; 2006 Aug; 16(2):125-30. PubMed ID: 16860716
[TBL] [Abstract][Full Text] [Related]
8. An in vivo model of hyperacute rejection: characterization and evaluation of the effect of transgenic human complement inhibitors.
Mora M; Lazzer M; Marsicano G; Mulder LC; Carraresi L; Pieri A; Benanchi A; Grifoni D; Nuti S; Bruzzone P; Comporti M; Cortesini R; Rossini M
Transgenic Res; 2000 Jun; 9(3):205-13. PubMed ID: 11032369
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons.
Loveland BE; Milland J; Kyriakou P; Thorley BR; Christiansen D; Lanteri MB; Regensburg M; Duffield M; French AJ; Williams L; Baker L; Brandon MR; Xing PX; Kahn D; McKenzie IF
Xenotransplantation; 2004 Mar; 11(2):171-83. PubMed ID: 14962279
[TBL] [Abstract][Full Text] [Related]
10. Tissue expression of human complement inhibitor, decay-accelerating factor, in transgenic pigs. A potential approach for preventing xenograft rejection.
Rosengard AM; Cary NR; Langford GA; Tucker AW; Wallwork J; White DJ
Transplantation; 1995 May; 59(9):1325-33. PubMed ID: 7539168
[TBL] [Abstract][Full Text] [Related]
11. Hyperacute lung rejection in the pig-to-human model. 2. Synergy between soluble and membrane complement inhibition.
Azimzadeh A; Zorn GL; Blair KS; Zhang JP; Pfeiffer S; Harrison RA; Cozzi E; White DJ; Pierson RN
Xenotransplantation; 2003 Mar; 10(2):120-31. PubMed ID: 12588645
[TBL] [Abstract][Full Text] [Related]
12. Protection of hDAF-transgenic porcine endothelial cells against activation by human complement: role of the membrane attack complex.
Fecke W; Long J; Richards A; Harrison R
Xenotransplantation; 2002 Mar; 9(2):97-105. PubMed ID: 11897002
[TBL] [Abstract][Full Text] [Related]
13. Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days.
Ramirez P; Chavez R; Majado M; Munitiz V; Muñoz A; Hernandez Q; Palenciano CG; Pino-Chavez G; Loba M; Minguela A; Yelamos J; Gago MR; Vizcaino AS; Asensi H; Cayuela MG; Segura B; Marin F; Rubio A; Fuente T; Robles R; Bueno FS; Sansano T; Acosta F; Rodriguez JM; Navarro F; Cabezuelo J; Cozzi E; White DJ; Calne RY; Parrilla P
Transplantation; 2000 Oct; 70(7):989-98. PubMed ID: 11045632
[TBL] [Abstract][Full Text] [Related]
14. HDAF transgenic pig livers are protected from hyperacute rejection during ex vivo perfusion with human blood.
Luo Y; Levy G; Ding J; Qi J; Chakbrati S; Garcia BM; Phillips MJ; Kumar N; Friend P; Noble L; Macdonald J; Zhong R; Grant D
Xenotransplantation; 2002 Jan; 9(1):36-44. PubMed ID: 12005103
[TBL] [Abstract][Full Text] [Related]
15. The influence of baseline expression of human decay accelerating factor transgene on graft survival and acute humoral xenograft rejection.
Sun H; Chen G; Liu W; Kubelik D; Yang H; White DJ; Zhong R; Garcia B
Transplantation; 2005 Nov; 80(9):1331-9. PubMed ID: 16314803
[TBL] [Abstract][Full Text] [Related]
16. Kidneys derived from mice transgenic for human complement blockers are protected in an in vivo model of hyperacute rejection.
Lazzeri M; Mora M; Mulder LC; Marsicano G; Marinucci G; Boschi M; Bruzzone P; Alfani D; Cortesini R; Rossini M
J Urol; 1998 Apr; 159(4):1364-9. PubMed ID: 9507885
[TBL] [Abstract][Full Text] [Related]
17. Effect of cell surface concentration of human DAF on transgenic pig aortic endothelial cells on the degree of protection afforded against human complement deposition.
Carrington CA; dos Santos Cruz G
Xenotransplantation; 2001 May; 8(2):100-5. PubMed ID: 11328580
[TBL] [Abstract][Full Text] [Related]
18. The serum level of xenoantibodies, and hDAF or alphaGAL expression on pig cells, modulate in vitro the protection given by hDAF to primate complement-mediated damage.
Díaz TM; Mañez R; Moscoso I; López D; Santamarina I; Lopez E; Centeno A; Domenéch N
Transplant Proc; 2005; 37(1):510-1. PubMed ID: 15808692
[TBL] [Abstract][Full Text] [Related]
19. Porcine MCP gene promoter directs high level expression of human DAF (CD55) in transgenic mice.
Murakami H; Takahagi Y; Yoshitatsu M; Miyagawa S; Fujimura T; Toyomura K; Shigehisa T; Shirakura R; Kinoshita T
Immunobiology; 2000 Apr; 201(5):583-97. PubMed ID: 10834315
[TBL] [Abstract][Full Text] [Related]
20. Morphology of hDAF (CD55) transgenic pig kidneys following ex-vivo hemoperfusion with human blood.
Storck M; Abendroth D; Prestel R; Pino-Chavez G; Müller-Höker J; White DJ; Hammer C
Transplantation; 1997 Jan; 63(2):304-10. PubMed ID: 9020335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
